Saturday, July 11, 2026

pharma · Phelan-McDermid Syndrome

Jiangnan University

Jiangnan University clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
1902 Founded
1,230 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Founded
1902
Employees
1,230
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Jiangnan University projects

1 ClinicalTrials.gov programs sponsored by Jiangnan University.

Jiangnan University has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. recombinant human growth hormone

    Affiliated Hospital of Jiangnan University

    Phelan-McDermid Syndrome

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Jiangnan University have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.